LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,782 | -16.3% | 56,595 | 0.0% | 0.00% | – |
| Q2 2023 | $79,799 | +9.3% | 56,595 | +19.6% | 0.00% | – |
| Q1 2022 | $73,000 | -37.1% | 47,315 | 0.0% | 0.00% | – |
| Q4 2021 | $116,000 | -4.1% | 47,315 | -1.4% | 0.00% | – |
| Q3 2021 | $121,000 | -11.7% | 47,970 | 0.0% | 0.00% | – |
| Q2 2021 | $137,000 | +179.6% | 47,970 | -19.1% | 0.00% | – |
| Q1 2020 | $49,000 | -23.4% | 59,324 | -17.3% | 0.00% | – |
| Q4 2019 | $64,000 | +42.2% | 71,725 | +55.1% | 0.00% | – |
| Q3 2019 | $45,000 | – | 46,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |